Synonyms: RP 57669 | RP-57669 | RP57669 | Synercid® (dalfopristin + quinupristin)
quinupristin is an approved drug (FDA (1999))
Compound class:
Synthetic organic
Comment: Quinupristin is a semi-synthetic derivative of streptogramin B. It inhibits the late stage of protein synthesis by binding to the bacterial 50S ribosomal subunit.
|
|
Classification ![]() |
|
Compound class | Synthetic organic |
Approved drug? | Yes (FDA (1999)) |
Approved drug? | Yes. FDA (1999) |
International Nonproprietary Names ![]() |
|
INN number | INN |
6582 | quinupristin |
Synonyms ![]() |
RP 57669 | RP-57669 | RP57669 | Synercid® (dalfopristin + quinupristin) |
Database Links ![]() |
|
Specialist databases | |
Antibiotic DB
![]() |
Quinupristin | Quinupristin/dalfopristin (Synercid) |
Other databases | |
CAS Registry No. | 120138-50-3 (source: WHO INN record) |
ChEMBL Ligand | CHEMBL1200649 |
GtoPdb PubChem SID | 405560239 |
PubChem CID | 5388937 |
Search Google for chemical match using the InChIKey | WTHRRGMBUAHGNI-LCYNINFDSA-N |
Search Google for chemicals with the same backbone | WTHRRGMBUAHGNI |
Search PubMed clinical trials | quinupristin |
Search PubMed titles | quinupristin |
Search PubMed titles/abstracts | quinupristin |
UniChem Compound Search for chemical match using the InChIKey | WTHRRGMBUAHGNI-LCYNINFDSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | WTHRRGMBUAHGNI-LCYNINFDSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖
Quinupristin (links to external site)
Cat. No. HY-A0162 |